Autophagy as a target for glucocorticoid-induced osteoporosis therapy

Area of Science:

• Cell Biology
• Molecular Biology
• Pathology

Background:

• Autophagy regulates eukaryotic cell function and disease progression.
• Autophagy is increasingly recognized for its role in bone homeostasis, involving key bone cells.
• Autophagy is implicated in the pathogenesis of glucocorticoid-induced osteoporosis (GIOP).

Purpose of the Study:

• To review the mechanisms by which autophagy impacts GIOP.
• To explore the association between autophagy and GIOP therapy.

Main Methods:

• Literature review of studies on autophagy and GIOP.
• Analysis of molecular pathways involved in autophagy and bone metabolism.
• Examination of therapeutic strategies targeting autophagy for GIOP.

Main Results:

• Autophagy plays a vital role in the function of osteoclasts, osteocytes, mesenchymal stem cells, and osteoblasts.
• Dysregulation of autophagy contributes to GIOP development.
• Autophagy modulation presents potential therapeutic avenues for GIOP.

Conclusions:

• Understanding autophagy's role in GIOP pathogenesis is key for developing effective treatments.
• Combining autophagy modulators with existing therapies may offer novel approaches for GIOP.
• Targeting autophagy, including BCL2 family proteins and caspase-dependent pathways, shows promise for GIOP clinical treatment.